Reporting Negative Control and Falsification Analyses

Why Reporting Details Determine Diagnostic Value

A negative-control or falsification analysis is useful only to the extent that its logic is visible. A reader needs to know why the control should not respond causally to the exposure, why it might nevertheless reveal bias, and whether the analysis was sufficiently similar to the primary analysis to make its result informative. Reporting only that a control association was “significant” or “not significant” does not answer these questions.

The earlier material on negative controls and falsification tests distinguishes several designs, including control outcomes, control exposures, and placebo treatments. The reporting principles are shared, but the causal rationale differs by design. In every case, the control result is a diagnostic for particular violations of assumptions—not a general certificate that the primary causal estimate is unbiased.

These definitions include two distinct claims. First, the proposed control must lack the causal pathway being tested. Second, it must have a reason to be informative about a bias mechanism relevant to the primary analysis. The first claim makes it a negative control; the second gives it diagnostic value. A control with no causal effect but no shared causes, measurement process, or selection mechanism may be uninformative even when its association is near zero.

What a Complete Report Needs to Establish

For each control, report the scientific rationale rather than relying on the label “negative control.” Name the exposure, outcome, target population, and time window. Explain why a causal effect is ruled out or implausible, and identify the specific bias pathway the test is intended to probe. If the justification depends on a causal diagram or substantive knowledge, describe the relevant relationships in words.

Timing is part of that justification. For a future exposure used as a control for a prior outcome, state the measurement dates or windows and explain why the future exposure cannot cause the earlier outcome. For a future outcome, specify whether the exposure could plausibly affect it through delayed effects. For a placebo treatment or period, clarify why the purported treatment did not occur in that period and why anticipation, carryover, or earlier treatment effects are not expected to generate a genuine association.

State the assumptions that connect the control to the primary analysis. For example, a control outcome may be causally unaffected by treatment but still share unmeasured causes with the primary outcome. If the control outcome is also affected by treatment through an unrecognized pathway, an association is no longer a clean falsification signal. Likewise, a future exposure can be associated with a past outcome through common causes, but reverse timing alone does not guarantee that it shares the confounding structure of the primary exposure.

A report should also describe the analysis itself: the study sample, eligibility criteria, missing-data handling, adjustment variables, estimator, and any weighting, matching, or clustering used. State whether the control analysis followed the primary analysis plan and explain any departures. If a different model was needed because the control outcome has a different distribution, say so and state how the resulting scale differs. The aim is not to force identical models where they are unsuitable, but to make the comparison interpretable.

Estimates, Scales, and Uncertainty

Report the control association as an estimate with a confidence interval and, where useful, a test result. Identify the effect scale explicitly: for example, a mean difference in score points, a risk difference in percentage points, a risk ratio, or an odds ratio. Include units for absolute effects. If a relative effect is estimated, state the reference group and whether the reported interval was constructed on a transformed scale.

For a large-sample Wald interval, an estimate \(\hat{\theta}\) with standard error \(SE\) has an approximate 95% interval \(\hat{\theta}\pm1.96SE\). A Wald test of \(H_0:\theta=0\) uses \(z=\hat{\theta}/SE\) for a difference scale; for a ratio, the test is generally conducted on the log scale against zero, equivalent to testing the ratio against one. These procedures depend on the estimator’s sampling approximation and standard-error calculation. State if inference instead used a bootstrap, randomization procedure, or another method.

When effects are reported on different scales, do not compare their numerical magnitudes as if they were interchangeable. A mean difference, a risk difference, and a risk ratio describe different contrasts. If a comparison with the primary estimate is substantively important, explain the scale conversion or report a compatible scale for both analyses, along with the assumptions needed for that comparison.

Transparent Reporting of Relative Effects

For relative measures, present the scale and the uncertainty method clearly. A ratio estimate is often analyzed on the logarithmic scale, where a Wald interval is formed and then exponentiated. The interval’s null value is one, not zero. Reporting only the exponentiated estimate without its interval or scale makes it difficult to judge whether the control result is precise or compatible with a meaningful association.

Multiplicity, Diagnostics, and Interpretation

When several controls or outcomes are tested, report how many were prespecified, which were selected after seeing the data, and how multiplicity was handled. If adjusted \(p\)-values or simultaneous intervals are provided, identify the procedure. Present the family of results together when possible: a single selected control can give a misleading impression, especially when several tests were conducted. Distinguish confirmatory tests from exploratory checks.

Useful diagnostics include checking that the intended time ordering holds, that the control has adequate sample size and outcome variation, and that the same definitions and adjustment choices were applied as planned. Examine whether missingness or sample restriction differs materially between the control and primary analyses. A null estimate with a wide interval may indicate low information rather than reassuring evidence. A non-null result may reflect residual confounding, but it may also signal a genuine causal pathway, an incorrect timing assumption, selection bias, measurement error, or model misspecification.

A concise interpretation should connect the estimate to its intended diagnostic role without overclaiming. If the association is nonzero, say which assumptions or bias mechanisms it makes less credible and which alternative explanations remain. If the estimate is near zero, report its precision and explain that it only weakens concern about mechanisms the control was capable of detecting. Neither result proves the assumptions for the primary causal analysis.

Common Reporting Pitfalls

• Calling a control a “test of no confounding.” It tests a particular implication under stated assumptions; it cannot detect every source of bias.
• Using timing as the whole justification. Temporal ordering may exclude one causal direction, but it does not establish shared confounding or rule out anticipation and carryover.
• Reporting only a \(p\)-value. Give the estimate, scale, interval, sample, and model so readers can assess magnitude and precision.
• Treating a non-significant result as proof of no association. The interval may include consequential associations, especially with limited precision.
• Subtracting a control estimate from the primary estimate without justification. A control association does not automatically quantify bias in the primary effect; calibration requires additional assumptions.